Pfizer Leads the Dow Higher

The Dow is up despite a starkly negative consumer confidence reading. As of 1:25 p.m. EST, the Dow Jones Industrial Average (DJINDICES: ^DJI  ) is up 67 points, or 0.48%. The S&P 500 (SNPINDEX: ^GSPC  ) is up six points, or 0.41%.

There were two U.S. economic releases this morning.





Case-Shiller Home Price Index




Conference Board Consumer Confidence Index




Source: MarketWatch U.S. Economic Calendar.

This morning Standard & Poor's reported that the Case-Shiller Home Price Composite-20 Index fell 0.1% in November to 145.82. While slightly down month over month, that's still a 5.5% increase year over year, bringing the index back to its fall 2003 level. The housing market strengthened throughout 2012, helping the economy and bringing homebuilding and home improvement stocks up with it. We'll have to wait and see if the housing market can continue to strengthen through 2013.

Also this morning, the Conference Board reported that its Consumer Confidence Index fell to 58.6 in January. That's far below last month's 66.7 and analyst expectations of a drop to 64.3. Consumers' confidence dropped across all measures, including current conditions, labor market, and their short-term outlook. Consumers have some good reasons to be negative -- particularly the 50% increase in the payroll tax, which will cost the average consumer roughly $1,000 a year.

Today's Dow leader
Today's Dow leader is Pfizer (NYSE: PFE  ) up 3.12% to $27.69. The pharmaceutical giant reported its fourth-quarter earnings this morning. Earnings fell year over year to $0.47 per share. That's better than analyst expectations of $0.44 per share and also better than Estimize's wisdom-of-the-crowds expectations of $0.45 per share. Revenue was down 7% from last year's $16.1 billion to $15.1 billion, but this nonetheless beat expectations of $14.4 billion. Revenue fell as a result of the long-expected loss of exclusivity for Lipitor. With this loss of exclusivity, generics are now allowed into the market.

Pfizer and its investors have known for years that Lipitor was coming off patent, and the company has been taking steps to build  its pipeline and replace the expiring blockbuster drug. The company has also made efforts to return value to shareholders by increasing its quarterly dividend, buying back large amounts of shares ($3.4 billion in Q4 and $8.2 billion for 2012) and spinning off its animal health division.

The Motley Fool's chief investment officer has selected his No. 1 stock for the next year. Find out which stock it is in our brand-new free report: "The Motley Fool's Top Stock for 2013." I invite you to take a copy, free for a limited time. Just click here to access the report and find out the name of this under-the-radar company.

Read/Post Comments (0) | Recommend This Article (3)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2222191, ~/Articles/ArticleHandler.aspx, 8/30/2016 3:28:20 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 6 hours ago Sponsored by:
DOW 18,502.99 107.59 0.58%
S&P 500 2,180.38 11.34 0.52%
NASD 5,232.33 13.41 0.26%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

8/29/2016 4:00 PM
PFE $35.11 Up +0.29 +0.83%
Pfizer CAPS Rating: ****